Personalis, Inc. (PSNL)
17.06
-1.32
(-7.18%)
USD |
NASDAQ |
Aug 24, 16:00
17.29
+0.23
(+1.35%)
After-Hours: 04:09
Personalis EPS Diluted (Quarterly) : -0.3005 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.3005 |
| March 31, 2026 | -0.2882 |
| December 31, 2025 | -0.258 |
| September 30, 2025 | -0.2441 |
| June 30, 2025 | -0.2266 |
| March 31, 2025 | -0.1801 |
| December 31, 2024 | -0.2254 |
| September 30, 2024 | -0.6403 |
| June 30, 2024 | -0.2443 |
| March 31, 2024 | -0.2559 |
| December 31, 2023 | -0.536 |
| September 30, 2023 | -0.5976 |
| June 30, 2023 | -0.5025 |
| March 31, 2023 | -0.6132 |
| December 31, 2022 | -0.6715 |
| September 30, 2022 | -0.5769 |
| June 30, 2022 | -0.6036 |
| Date | Value |
|---|---|
| March 31, 2022 | -0.6269 |
| December 31, 2021 | -0.4508 |
| September 30, 2021 | -0.397 |
| June 30, 2021 | -0.3401 |
| March 31, 2021 | -0.2935 |
| December 31, 2020 | -0.3424 |
| September 30, 2020 | -0.2692 |
| June 30, 2020 | -0.2917 |
| March 31, 2020 | -0.2916 |
| December 31, 2019 | -0.2127 |
| September 30, 2019 | -0.2211 |
| June 30, 2019 | -0.8896 |
| March 31, 2019 | -0.1838 |
| December 31, 2018 | -0.1149 |
| September 30, 2018 | -0.1177 |
| June 30, 2018 | -0.2364 |
| March 31, 2018 | -0.1737 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Tempus AI, Inc. | 0.0309 |
| 10X Genomics, Inc. | -0.138 |
| Alamar Biosciences, Inc. (California) | -0.1902 |
| Adaptive Biotechnologies Corp. | -0.2489 |
| Champions Oncology, Inc. | -0.048 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -31.68M |
| Revenue (Quarterly) | 22.36M |
| Total Expenses (Quarterly) | 54.04M |
| Enterprise Value | 1.640B |
| Gross Profit Margin (Quarterly) | 21.21% |
| Profit Margin (Quarterly) | -141.7% |
| Earnings Yield | -6.39% |
| Normalized Earnings Yield | -6.394 |